Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitors ...
The announcements were not based on any new evidence or research on the relationship between Tylenol use and autism or ...
Pilavapadin 10 mg resulted in a two-point reduction from baseline in average daily pain scores (ADPS) by week 11 and was well tolerated in PROGRESS Phase 2b study ...
Presentation Highlighted Data Supporting Clinical Benefit of GTx-104 Compared to Orally Administered Nimodipine in the Treatment of aneurysmal Subarachnoid Hemorrhage (aSAH)PRINCETON, N.J., Sept. 22, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results